Vontobel Holding Ltd. Has $1.90 Million Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Vontobel Holding Ltd. decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 31.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 21,277 shares of the exchange traded fund’s stock after selling 9,554 shares during the period. Vontobel Holding Ltd.’s holdings in SPDR S&P Biotech ETF were worth $1,900,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in XBI. Resources Management Corp CT ADV boosted its holdings in SPDR S&P Biotech ETF by 1,715.8% in the 2nd quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock valued at $29,000 after purchasing an additional 326 shares during the period. Tyler Stone Wealth Management acquired a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $33,000. Compass Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $34,000. Fortis Capital Advisors LLC acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $38,000. Finally, EPG Wealth Management LLC increased its stake in SPDR S&P Biotech ETF by 152.7% during the 3rd quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after acquiring an additional 278 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $82.81 on Friday. The stock has a market capitalization of $6.43 billion, a PE ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The business has a fifty day moving average price of $93.52 and a two-hundred day moving average price of $84.21.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.